Abstract
Pulmonary endarterectomy (PEA) offers a potentially curable treatment for chronic thromboembolic pulmonary hypertension (CTEPH). However, outcomes are often unpredictable, with residual high pulmonary vascular resistance (PVR) and persisting symptoms frequently observed despite successful resection of thromboembolic material. The severity of CTEPH is predominantly based on the magnitude of PVR and successful treatment defined by the normalisation of PVR post PEA. Pulmonary compliance (PCa), the distensibility of the arterial wall, characteristically decreases in CTEPH, even preceding increases in PVR; however, it is not routinely measured in these patients.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call